An interventional study of Red teff (Eragrostis teff) porridge in Anaemia, sponsored by Debre Markos University. Completed at 1 site in Ethiopia. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Debre Markos University · Not applicable, Interventional, and Supportive care
Background. Childhood anemia affects more than 40% of under-five children in Ethiopia, where iron supplementation has achieved limited success and locally grounded, sustainable strategies are needed. Red teff (Eragrostis tef) is an iron-rich, gluten-free staple crop. We evaluated whether a red teff porridge improves hemoglobin in anemic infants and toddlers, and quantified its cost and potential environmental impact relative to animal-source iron-rich foods.
Methods. In a self-controlled pre-post feeding trial in East Gojjam Zone, Ethiopia, anemic children received 42 g home-prepared red teff porridge providing about 77 mg iron per day for 60 days. The primary outcome, the change in hemoglobin, was analyzed with covariate-adjusted models (n = 32 after excluding one implausible value), with covariates selected on biological grounds and additionally screened by cross-validated LASSO. The cost and greenhouse-gas emissions (GHGE) of red teff were compared with beef, lamb and egg per milligram of absorbed iron and per gram of protein, with substitution and sensitivity analyses.
1,810 studies on the registry are indexed under Anemia; 215 are open to participants now.
This study's enrollment of 32 is below the median of 117 across 1,336 interventional studies indexed under Anemia.
Browse Anemia studies →Debre Markos University is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Child who had any physical deformities ,/AIDS, diabetes mellitus and cancer.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In this study, children were provided with 42 g of porridge prepared from red teff daily for 60 days
Dietary Supplement: Red teff (Eragrostis teff) porridge
In each household, mothers/caregivers were educated how they prepare porridge made from Red teff (Eragrostis teff). For single serving a total of 50 g of red teff flour was mixed with 50 mL of water in a small plastic bowl to form a slurry, which was then set aside. In a stainless-steel pan, 50 mL of distilled water was boiled. Once the water boiled the slurry was added to the pan and cooked for 15 minutes at 90°C with continuous stirring to prevent coagulation and sticking. After cooking, the porridge was removed from the heat and prepared for child consumption. According to the fact that non-heme iron has a bioavailability of 10-15%, and the recommended daily allowance of iron for children aged 1-3 years is 7 mg/day. In this study, children were provided with 42 g of porridge daily for 60 days.
mean Hemoglobin level of children
Time frame: It was assessed after 60 days
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Debre Markos University